Panacea Life Sciences Holdings, Inc. Available-for-sale Securities, Gross Realized Gain (Loss)
Panacea Life Sciences Holdings, Inc. (PLSH) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2017-03-31
- Panacea Life Sciences Holdings, Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2015-12-31 was $12.42K.
- Panacea Life Sciences Holdings, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Panacea Life Sciences Holdings, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2015 was $6.21K.
- Panacea Life Sciences Holdings, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2014 was -$108.32K.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-31 | ||
| 2015-12-31 | $12.42K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $6.21K 10-K · filed 2017-03-31 | |
| 2015-09-30 | -$6.21K 10-Q · filed 2015-11-06 | ||
| 2014-12-31 | -$108.32K 10-K · filed 2016-02-29 |